Deerfield Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-35,154
| Closed | -$541K | – | 109 |
|
2024
Q3 | $541K | Buy |
+35,154
| New | +$541K | 0.01% | 275 |
|
2024
Q1 | – | Sell |
-9,728
| Closed | -$305K | – | 368 |
|
2023
Q4 | $305K | Buy |
+9,728
| New | +$305K | 0.01% | 117 |
|
2015
Q2 | – | Sell |
-49,400
| Closed | -$1.61M | – | 123 |
|
2015
Q1 | $1.61M | Buy |
+49,400
| New | +$1.61M | 0.05% | 101 |
|
2013
Q3 | – | Sell |
-1,067,115
| Closed | -$19.4M | – | 103 |
|
2013
Q2 | $19.4M | Buy |
+1,067,115
| New | +$19.4M | 0.91% | 46 |
|